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User testingAbstract Background: Patient information leaﬂets are universally-accepted resources to educate
the patients/users about their medications, disease and lifestyle modiﬁcation. Objectives: The objec-
tive of the study was to prepare, validate and perform user-testing of pictogram-based patient infor-
mation leaﬂets (P-PILs) among hemodialysis (HD) patients. Methods: The P-PILs are prepared by
referring to the primary, secondary and tertiary resources. The content and pictograms of the leaﬂet
have been validated by an expert committee consisting of three nephrologists and two academic
pharmacists. The Baker Able Leaﬂet Design has been applied to develop the layout and design
of the P-PILs. Results: Quasi-experimental pre- and post-test design without control group was con-
ducted on 81 HD patients for user-testing of P-PILs. The mean Baker Able Leaﬂet Design assess-
ment score for English version of the leaﬂet was 28, and 26 for Kannada version. The overall user-
testing knowledge assessment mean scores were observed to have signiﬁcantly improved from 44.25
to 69.62 with p value <0.001. Conclusion: The overall user opinion of content and legibility of the
622 U.V. Mateti et al.leaﬂets was good. Pictogram-based patient information leaﬂets can be considered an effective edu-
cational tool for HD patients.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Verbal communication often fails because the information
may be misunderstood and/or forgotten (Renuka and
Pushpanjali, 2013). Patient information leaﬂets (PILs) are uni-
versally-accepted materials to educate patients/users about the
medications, disease and lifestyle modiﬁcation (Newton et al.,
1998; Al-Maskari et al., 2013). Therefore, PILs may be consid-
ered as a tool for supplementing health education. PILs can be
preserved and gladly passed from person to person without
getting crumpled (Meillier et al., 1999). Pictogram-based
patient information leaﬂets (P-PILs) are the advanced version
of PILs. The information presented in P-PILs with suitably
validated pictograms is used for better patient understanding.
The ideal P-PILs can be validated by subject experts with good
readability, legibility and content (Kenny et al., 1998).
P-PILs are the best tools for patients with chronic diseases
such as diabetes, hypertension, asthma and chronic kidney
disease. To achieve the positive therapeutic outcome for these
diseases, self-care becomes inevitability (Mateti et al., 2013).
The PILs study conducted by Adepu and Swamy (2012) has
shown the improved the levels of knowledge, attitude and
practice of the patients. Several studies have revealed that
there is a lack of knowledge regarding the drugs, disease and
lifestyle modiﬁcation among chronic kidney disease patients
on hemodialysis (HD) (Sathvik et al., 2007 and Schmid
et al., 2009). The self-care regarding ﬂuid management, man-
aging the thirst, salt management, nutritional information is
very much important in HD patients (Mateti et al., 2013).
The objective of the study was to prepare, validate and
perform user-testing of P-PILs in HD patients.
2. Methods
2.1. Study design, setting and patients
A quasi-experimental pre- and post-test design without control
group was conducted for a period of 12 months between June
2013 and May 2014 at three different HD units of academic,
government and corporate hospitals. Approval of the Institu-
tional Ethics Committee (IEC) was obtained prior to the initi-
ation of the study. The present study was carried out as part of
a larger study on the impact of pharmaceutical care plan on
health-related quality of life among HD patients. HD patients
on pharmaceutical care group with minimum primary educa-
tional background were selected from the out-patient HD unit
from all the three units. The inclusion criterion was based on
the patients undergoing HD continuously for 3 months in
the age group of 18–75 years, with a written informed consent.
The socio-demographic details such as age, gender, educa-
tional status, economic status, length of time spent on HD
and co-morbidities were collected from the patients. The
socio-economic status of the patients was calculated using
the Kuppuswamy socio-economic scale (Kumar et al., 2012).2.2. Sample size
The sample size was calculated on the basis of the change in
patient’s knowledge of user-testing scores from baseline to
post-intervention scores by using the following formula.
n ¼ ðZ1a=2 þ Z1bÞ
2r2
d2
þ 2
r= 10, Z1a/2 is 1.96 (for a= 5%).
Z1b is 0.84 for 80% power and d= 5.
r is the mean of the two standard deviations.
d is the minimum signiﬁcant difference in the two groups.
The minimum sample required for this study is 40.
2.3. Preparation, validation and translation of P-PILs
The patient information leaﬂets were prepared by referring to
the primary, secondary and tertiary resources. Tertiary
resources included textbooks on nutritive values of Indian
foods and textbook of Pharmacotherapy and guidelines of
National Kidney Foundation, Kidney Disease Outcomes
Quality Initiative Clinical Practice guidelines, Indian Associa-
tion of Nephrology guidelines and publications from National
Kidney Disease Education Program and Renal Nutrition
Forum. The secondary resources were various databases such
as Micromedex, Up-to-date, Medscape, Medline and Web
MD. The primary resources include various articles related
to HD. Content of the leaﬂet includes information on ﬂuid,
thirst, salt, potassium and anemia management, energy and
proteins turnover, phosphorous and calcium balance, micro-
nutrient supplements, drugs to be avoided, vaccinations,
monitoring of laboratory tests based on monthly, tri-monthly
and half-yearly and annual, and the information of commonly
prescribed medications has been included. The content and
pictograms of the leaﬂet have been validated by an expert com-
mittee consisting of three nephrologists and two academic
pharmacists. The changes were made as per the directions of
the expert committee and the leaﬂet was prepared after assess-
ing the characteristics of layout and design of P-PIL by using
Baker Able Leaﬂets Design method (Baker, 1997; Gibbs et al.,
1989). The validated English version of leaﬂet was translated
into Kannada by using a three-step process of forward
translation, backward translation and patient-testing.
2.4. Readability testing of P-PILs
Readability was assessed by user-testing questionnaire. For
this user-testing, 10 multiple-choice questions have been
prepared based on the content of the leaﬂet. The questionnaire
was validated and readability was checked. During the user-
testing, questionnaire was administered to the HD patients
on pharmaceutical care group for assessing baseline knowledge
followed by provision of leaﬂet (English or Kannada) to the
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to read for 20 min, patients were again administered the same
questionnaire to assess the knowledge. At the end of the study,
the response was evaluated using the following formula.
Response Evaluation¼Total number of correct responses patient
Total number of actual responses
100
After knowledge assessment, opinion of the patients was
elicited about the content, layout and design in a rating form
containing 4 questions and the scores were ranged on 5–1
scale. The interpretation of the scores is as follows:
– Good = If the score of legibility and content of the P-PILs
is ‘20-14’.
– Average = If the score of legibility and content of the
P-PILs is ‘14-9’.
– Poor = If the score of legibility and content of the P-PILs is
‘Less than 9’.
2.5. Validation and reliability of user-testing and user-opinion
testing questionnaire
Validation and reliability of user-testing and user-opinion test-
ing questionnaire were checked before assessing the knowledge
and user opinion from the patients. The user-testing and user-
opinion questionnaire was validated by an expert committee.
Test re-test reliability was assessed with a sub-sample of 24
randomly selected HD patients by administering Kannada
and English versions twice of user-testing and user-opinion
questionnaire a week apart.
2.6. Statistical analysis
In order to assess the test–retest reliability of user-testing and
user-opinion questionnaire, the intraclass correlation coefﬁ-
cients (ICC) were computed among randomly selected HD
patients. An ICCP 0.9 has been considered highly reliable
while ICC between 0.7 and 0.89 as moderately reliable and
an ICC< 0.7 as having low reliability. Descriptive Statistics
has been used to summarize the data and the user-testing data
of baseline and after 20 minutes, scores were computed by
using ‘paired student t test’ with ‘p’ value less than 0.05 consid-
ered as statistically signiﬁcant. Data were analyzed using SPSS
version 15 software, Bangalore, South Asia.Table 1 Test re-test reliability of user-testing and opinion question
Type of questionnaire Test 1 (Day 1
scores)
(Mean ± SD)
Test 2 (Day 7
scores)
(Mean ± SD)
Mea
[Sign
User testing Kannada
version (n= 12)
45.83 ± 13.72 44.25 ± 10.83 1.57
User testing English
version (n= 12)
48.79 ± 10.76 49.62 ± 12.75 0.8
User opinion Kannada
version (n= 12)
16.08 ± 2.23 16.41 ± 2.19 0.3
User opinion English
version (n= 12)
14.66 ± 1.92 15.25 ± 1.86 0.5
SD – standard deviation; NS – not signiﬁcant; ICC – intraclass correlati3. Results
3.1. Test-retest reliability of user-testing and user-opinion
questionnaire
Out of 24 patients, 12 were assessed for Kannada and remain-
ing 12 were assessed for English version of the questionnaire.
The intraclass correlation coefﬁcient (ICC) reliability for both
the versions of the questionnaire ranged from 0.92 to 0.98. The
ICC reliability values, 95% conﬁdence intervals, means and
standard deviation scores of both the versions of Kannada
and English results are summarized in Table 1.
3.2. Scores of Baker Able Leaﬂet Design
The mean Baker Able Leaﬂet Design assessment score for
English version of leaﬂet was 28 and 26 for Kannada version.
3.3. Socio-demographic details of the Patients
A total of 100 patients were in the pharmaceutical care group.
Eighty one of these patients were included in the study and 19
patients were excluded from the study. As these 19 patients
were illiterate the patient information leaﬂets were provided
to the attendants of the patients. Out of 81 patients, 45 were
selected from academic hospital, 28 from corporate hospital
and 8 from government hospital. Most of the patients were
men (77.77%) with high school educational background
(29.62%) and had lower middle socio-economic status
(34.56%). The results of socio-demographic details of the
patients are summarized in Table 2.
3.4. User-testing and user-opinion scores of leaﬂets
The Kannada leaﬂet users outnumbered the English leaﬂet
users, of which 50 Kannada users constitute 61.72% while 31
English users, 38.27%. The overall user-testing knowledge
assessment mean scores signiﬁcantly improved from 44.25 to
69.62 with p value <0.001. The detailed user-testing scores
of Kannada and English versions of leaﬂets are summarized
in Table 3. The overall user opinion of legibility and content
of the leaﬂets was good i.e., 81.14%. The detailed user-opinion
scores of Kannada and English versions of leaﬂets are
summarized in Table 4.naire.
n diﬀerence ± SD, (range) ICC value 95% CI
iﬁcance]
± 5.98, (11, 10), [NS, p 0.38] 0.93 0.79–0.98
3 ± 2.88 (10, 0), [NS, p 0.33] 0.98 0.95–0.99
3 ± 1.15 (2, 2), [NS, p 0.33] 0.92 0.75–0.97
8 ± 0.79, (2, 0), [signiﬁcant, p 0.02] 0.95 0.68–0.98
on coefﬁcient; CI – conﬁdence interval.
Table 4 User-opinion scores of P-PILS.
Type of leaﬂet user-opinion ratingNumber of patients (%) (n= 81)
Kannada
Good 40 (80)
Average 10 (20)
Poor –
English
Good 26 (83.87)
Average 5 (16.12)
Poor –
Overall P-PILs users
Good 66 (81.14)
Average 15 (18.51)
Poor –
Table 2 Socio-demographic details of patients.
Socio-demographic details Number of patients (%)
Age, Mean ± SD 52.37 ± 12.80
Gender
Male 63 (77.77)
Female 18 (22.22)
Educational status
Primary School 8 (9.87)
Middle School 11(13.58)
High School 24 (29.62)
Intermediate 16 (19.75)
Graduate 22 (27.16)
Socio-economic status
Upper 3 (3.70)
Upper middle 27 (33.33)
Lower middle 28 (34.56)
Upper lower 22 (27.16)
Lower 1 (1.12)
Length of the time spent on hemodialysis (months)
Median (IQR) 48 (72,16)
Hypertension
Yes 100 (100)
No –
Diabetes mellitus
Yes 24 (29.62)
No 57 (70.37)
Anemia
Yes 100 (100)
No –
SD – standard deviation and IQR – interquartile range.
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The present study is the ﬁrst of its kind in India conducted on
preparation, validation and user-testing of pictogram-based
patient information leaﬂets for HD patients. The previous
studies were conducted on preparation, validation and reliabil-
ity of patient information leaﬂets for diabetes, hypertension,
diabetic foot ulcer, rheumatoid arthritis, asthma, peptic ulcer,
and tuberculosis (Adepu and Swamy, 2012; Hill and Bird,
2003; Roy et al., 2013; Rajan et al., 2013). The mean Baker
Able Leaﬂet Design score of English version leaﬂet was better
than the leaﬂets prepared by the similar studies (Adepu and
Swamy, 2012; Roy et al., 2013). When compared the leaﬂets
prepared by Rajan et al. (2013) had better score for English
version and lesser score for Kannada version leaﬂet. The
previously conducted studies were tested for readability ofTable 3 User-testing scores of P-PILS.
Type of users Pre-test scores (Mean ± SD) Post-test sco
English (n= 31) 48.13 ± 11.63 77.92 ± 18
Kannada (n= 50) 41.84 ± 11.93 64.48 ± 18.9
Overall P-PILs users (n= 81) 44.25 ± 12.14 69.62 ± 19.6
SD – standard deviation.the leaﬂets by using the western developed formulas such as
Flesch Reading Ease, Flesch–Kincaid grade level and Simpli-
ﬁed Measure of Gobbledygook index readability (Flesh,
2014; Flesch and Kincaid, 2014; McLaughlin, 2014). In the
present study, user-testing was used to assess the readability
of the leaﬂets. User-testing is the accurate method to assess
the readability of the leaﬂets in any language. The readability
assessed by formulas can only be applied to the English version
leaﬂets and readability of other language leaﬂets was hitherto
unknown. The validity and readability of western developed
readability formulae for Indian languages were also unknown.
The study also collected the user-opinion of the leaﬂets in addi-
tion to the user-testing. Most of the published studies did not
assess the user-opinion on the leaﬂets which the present study
attempted as they are one of the important stakeholders in
patient education. The results of the study reveal that more
than 80% patients rated the leaﬂets content, legibility and
design as good. The reliability of the present study in user-test-
ing and user-opinion of the questionnaire is found to be P0.9
and is considered highly reliable.
It is evident from this study that the post-interventional
P-PILs knowledge-based user-testing scores signiﬁcantly
improved from baseline scores from 44.25 to 69.62 with p value
<0.001. The impact of pictograms in PILs in recalling the
information conducted by the Leiia and Ros (2003) has shown
similar improvements. The pre- and post-interventional PIL
study conducted in the community pharmacy observed that
the recall drug information signiﬁcantly improved from 30%
to 65% (Carina et al., 1996). The verbal advice along with
PIL is shown to have improved knowledge levels in recogniz-
ing the uses and side effects of medications from 40% to
67% (Gibbs et al., 1990). Similar studies conducted by others
with patient information leaﬂets as an educational interventionres (Mean ± SD) Mean diﬀerence ± SD, (range)
[Signiﬁcance]
29.78 ± 13, (50, 0), [signiﬁcant, p= 0.000]
7 22.64 ± 12.75, (60, 10), [signiﬁcant, p= 0.000]
2 25.37 ± 13.24, (60, 10), [signiﬁcant, p= 0.000]
Testing of pictogram-based patient information leaﬂets 625have signiﬁcant impact on the knowledge, attitude and practice
among the patients suffering from diabetes, hypertension,
asthma peptic ulcer and rheumatoid arthritis (Adepu and
Swamy, 2012; Sathvik et al., 2007; Hill and Bird, 2003; Louis
and Halparin, 1979).
5. Conclusion
The present study showed signiﬁcant improvement in knowl-
edge levels after reading the validated leaﬂets. More than
80% of patients rated the leaﬂets content, legibility and design
as good. The pictogram-based patient information leaﬂets
have been found to be an effective educational tool in HD
patients.
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